SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin

Acta Pharmacologica Sinica

Volumn 31, Issue 2, 2010, Pages 184-190

  Li, Qing ^a,b   Liu, Fang ^a,b   Zheng, Tai Shan ^a,b   Tang, Jun Ling ^a,b   Lu, Hui Juan ^a,b   Jia, Wei Ping ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Clinical Center of Diabetes   (China)

Author keywords

ASP PCR; Lactate; Metformin; Organic cation transporter 2; Single nucleotide polymorphism; SLC22A2 gene; Type 2 diabetes mellitus

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; LACTIC ACID; METFORMIN; ORGANIC CATION TRANSPORTER 2;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CHINESE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET RESTRICTION; DISEASE DURATION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLACTATEMIA; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHARMACOGENETICS; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; UREA NITROGEN BLOOD LEVEL;

BASE SEQUENCE; CHINA; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; HUMANS; HYPOGLYCEMIC AGENTS; LACTIC ACID; METFORMIN; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 76949107912     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.189     Document Type: Article

References (22)

1. Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs 2003; 63: 1879-1894
2. Hermann LS, Scherstén B, Bitzén PO, Kjellström T, Lindgärde F, Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations, a double- blind controlled study. Diabetes Care 1994; 17: 1100-1109
3. Dresser MJ, Xiao G, Leabman MK, Gray AT, Giacomini KM. Interactions of N-tetraalkylammonium compounds and biguanides with a human renal organic cation tranporter (hOCT2). Pharm Res 2002; 19: 1244-1247
4. Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, Inui K, et al. Metformin is a superior substrate for renal organic cation tranporter OCT2 rather than hepatic OCT1. Drug Metab Pharmacokinet 2005; 20: 379-386
5. Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, et al. Gene expression levels and immunolocalization of organic ion transproters in the human kidney. J Am Soc Nephrol 2002; 13: 866-874
6. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol 1997; 16: 871-881
7. Urakami Y, Nakamura N, Takahashi K, Okuda M, Saito H, Hashimoto Y, et al. Gender differences in expression of organic cation transporter OCT2 in rat kidney. FEBS Letters 1999; 461: 339-342
8. Urakami Y, Okuda M, Saito H, Inui K. Hormonal regulation of organic cation transporter OCT2 expression in rat kidney. FEBS Letters 2000; 473: 173-176
9. Asaka J, Terada T, Okuda M, Katsura T, Inui K. Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3. Pharm Res 2006; 23: 697-704.
10. Leabman MK, Giacomini KM. Estimating the contribution of genes and environment to variation in renal drug clearance. Pharmacogenetics 2003; 13: 581-584
11. Yin OQ, Tomlinson B, Chow M. Variability in renal clearance of substrates for renal transporters in Chinese subjects. J Clin Pharmacol 2006; 46: 157-163
12. Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 2002; 12: 395-405.
13. Wang ZJ, Yin OQ, Tomlinson B, Chow MS. The polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine. Pharmacogenet Genomics 2008; 18: 637-645
14. Radziuk J, Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 2001; 17: 250-272
15. Borst SE, Snellen HG, Lai HL. Metformin treatment enhances insulinstimulated glucose transport in skeletal muscle of Sprague-Dawley rats. Life Sci 2000; 67: 165-174
16. Wang DS, Kusuhara H, Kato Y, Jonker JW, Schinkel AH, Sugiyama Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Mol Pharmacol 2003; 63: 844-848
17. Nakamura A, Furuta T, Shirai N, Sugimoto M, Kajimura M, Soya Y, et al. Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction method. J Gastroenterol Hepatol 2007; 22: 1057-1063
18. Ishiguro A, Kubota T, Soya Y, Sasaki H, Yagyu O, Takarada Y, et al. High-throughput detection of multiple genetic polymorphisms influencing drug metabolism with mismatch primers in allele-specific polymerase chain reaction. Anal Biochem 2005; 337: 256-261
19. Korbie DJ, Mattick JS. Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat Protoc 2008; 3: 1452-1456
20. Fukushima-Uesaka H, Maekawa K, Ozawa S, Komamura K, Ueno K, Shibakawa M, et al. Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). Drug Metab Pharmacokinet 2004; 19: 239-244
21. Kang HJ, Song IS, Shin HJ, Kim WY, Lee CH, Shim JC, et al. Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population. Drug Metab Dispositon 2007; 35: 667-675
22. Hayer-Zillgen M, Brüss M, Bönisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br J Pharmacol 2002; 136: 829-836